AKTSAktis Oncology, Inc.vs its industry peers
A metric-by-metric comparison of Aktis Oncology, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKTSThis | $1.2B#3 | — | 2.5x#4 | — | — | — | — | 0.0%#1 | — | — | 23319.4%#1 | — |
| RARE | $1.3B#1 | — | — | 1.9x#1 | 20.2%#2 | -1.1%#2 | -79.5%#3 | — | — | — | — | — |
| OMER | $1.3B#2 | 10.0x#1 | — | 17.0x#4 | -34.0%#4 | 97.9%#1 | -166.4%#4 | — | -151.8%#4 | — | 328.7%#2 | — |
| OPK | $1.2B#4 | — | 1.0x#1 | 2.0x#2 | -14.9%#3 | -324.0%#8 | -19.3%#2 | -19058.1%#6 | -13.3%#2 | 4#1 | — | — |
| SPTX | $1.2B#5 | — | 2.8x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| MNKD | $1.1B#6 | — | — | 3.3x#3 | 22.2%#1 | -78.7%#5 | 11.1%#1 | — | 2283.8%#1 | — | — | — |
| MLTX | $1.1B#7 | — | 2.5x#3 | — | — | -91.1%#7 | — | -53.1%#4 | -491.6%#5 | — | -76.6%#5 | — |
| JBIO | $1.1B#8 | — | 2.4x#2 | — | — | -83.0%#6 | — | -29.0%#3 | — | — | 133.9%#3 | — |
| SVRA | $1.1B#9 | — | 7.4x#6 | 4109.2x#5 | — | -23.9%#4 | -48072.8%#5 | -82.7%#5 | -93.6%#3 | — | 41.8%#4 | — |
| OBX | $1.1B#10 | — | — | — | — | -21.1%#3 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice